Sabinsa Corporation has developed the “next generation of curcuminoids,” with the goal of addressing potency, color, dosage, stability and bioavailability concerns. Curcumin C3 Reduct (95% tetrahydrocurcuminoids) is a white powder with increased dosage efficiency that can be used in smaller capsules and tablets while retaining greater absorption, potency, stability and bioavailability.